Moderna, Inc.
MRNANasdaqFull coverage
Price
Loading your watchlists
Cash flow statement
For a spreadsheet set to a decimal comma. Applies to Copy table and Download CSV.
USD millions
| Line | Trend | FY 2025Ended Dec 31, | FY 2024Ended Dec 31, | FY 2023Ended Dec 31, | FY 2022Ended Dec 31, | FY 2021Ended Dec 31, | FY 2020Ended Dec 31, | FY 2019Ended Dec 31, | FY 2018Ended Dec 31, | FY 2017Ended Dec 31, | FY 2016Ended Dec 31, |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net income | |||||||||||
| Depreciation and amortization | |||||||||||
| Stock-based compensation | |||||||||||
| Deferred income taxes | |||||||||||
| Change in receivables, total | |||||||||||
| Change in receivables | |||||||||||
| Change in inventories | |||||||||||
| Change in payables and accrued liabilities | |||||||||||
| Change in payables | |||||||||||
| Cash from operating activities | |||||||||||
| Purchases of productive assets | |||||||||||
| Capital expenditure | |||||||||||
| Acquisitions, net of cash acquired | |||||||||||
| Purchases of investments | |||||||||||
| Purchases of available-for-sale debt securities | |||||||||||
| Sales and maturities of investments | |||||||||||
| Sales of available-for-sale debt securities | |||||||||||
| Maturities of available-for-sale securities | |||||||||||
| Cash from investing activities | |||||||||||
| Finance lease principal payments | |||||||||||
| Share repurchases | |||||||||||
| Cash from financing activities | |||||||||||
| Effect of exchange rates on cash | |||||||||||
| Net change in cash | |||||||||||
| Cash at end of period | |||||||||||
| Free cash flow | |||||||||||
| Interest paid | |||||||||||
| Income taxes paid | |||||||||||
| Operating lease payments | |||||||||||
| Right-of-use assets obtained for new operating leases | |||||||||||
Use the arrow keys to move between values, and Enter to see where a value comes from.
Growth
| Line | Q3 2026vs a year earlier | 1 year | 3 years | 5 years |
|---|---|---|---|---|
| Revenue | ||||
| Gross profit | ||||
| Diluted EPS | ||||
| Free cash flow | ||||
| Diluted share count |
Margins
| Margin | TTM Q4 2021Ended Dec 31, | TTM Q1 2022Ended Mar 31, | TTM Q2 2022Ended Jun 30, | TTM Q3 2022Ended Sep 30, | TTM Q4 2022Ended Dec 31, | TTM Q1 2023Ended Mar 31, | TTM Q2 2023Ended Jun 30, | TTM Q3 2023Ended Sep 30, | TTM Q4 2023Ended Dec 31, | TTM Q1 2024Ended Mar 31, | TTM Q2 2024Ended Jun 30, | TTM Q3 2024Ended Sep 30, | TTM Q4 2024Ended Dec 31, | TTM Q1 2025Ended Mar 31, | TTM Q2 2025Ended Jun 30, | TTM Q3 2025Ended Sep 30, | TTM Q4 2025Ended Dec 31, | TTM Q1 2026Ended Mar 31, | TTM Q2 2026Ended Jun 30, | TTM Q3 2026Ended Sep 30, |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | ||||||||||||||||||||
| Operating margin | ||||||||||||||||||||
| Net margin | ||||||||||||||||||||
| EBITDA margin | ||||||||||||||||||||
| FCF margin |